Letters
Initial drug treatment in Parkinson’s disease
Reboxetine has no antidepressant effect at all
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5842 (Published 03 November 2015) Cite this as: BMJ 2015;351:h5842- Richard Braithwaite, consultant psychiatrist1
- 1St Mary’s Hospital, Newport PO30 5TG, UK
- richard.braithwaite{at}iow.nhs.uk
Muzerengi and Clarke are correct to advise against the use of most antidepressants in combination with the monoamine oxidase B inhibitors, rasagiline and selegiline.1 But it …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.